William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Airline Perks Only the Super-Rich Will See

Some airline perks are only available to the super-rich. Showering mid-flight and having a real bed are just a couple of these perks.

Google Chrome Taking Heat Over Password Policy

Google Chrome is under fire for how it handles stored passwords. One software designer highlights the browsers lack of security on his blog.

California’s First Cellphone Amber Alerts Create Controversy

Amber Alerts sent via text messages in California are being met with mixed results. Many Californians were annoyed by the new system, other loved it.

Kellogg Taken to Task Over Rain Forest Destruction

Kellogg is being held responsible by environmental groups for the alleged deforestation being done by the company's palm oil provider, Wilmar International.

Woolworth’s Heiress Outspent a Near-Billion-Dollar Fortune, Died Poor

Barbara Hutton inherited almost a billion dollars due to her relation to Frank W. Woolworth. She spent all but $3,500 of it before she passed away.

The 5 Wealthiest U.S. CEOs

Wealth-X has has compiled a list of the top 10 wealthiest CEOs in America. Here are the top five from that list.

7 U.S. Cities to See Fast Food Strikes This Week

Fast food workers in seven cities plan to protest for higher wages on Monday. The workers want to become unionized and receive wages of $15 an hour.

Pfizer to Sell Vaccine to Poor Countries for Fraction of Price

Pfizer has agreed to sell its vaccine Prevnar 13 to poor countries for a fraction of the price. The vaccine will be sold for $3.50 until 2025.

5 Indicted in $300M Credit Card Fraud Spree

Federal prosecutors have charged five men for credit card fraud that has cost companies $300 million. Two of the men are currently in custody.

GlaxoSmithKline to Pay $229M to Settle Diabetes Drug Suit

GlaxoSmithKline announced Wednesday, that it will spend $229 million to settle lawsuits concerning the advertising of its diabetes drug Avandia.